P3 Health Partners Inc. Common Stock (PIII) is a publicly traded Healthcare sector company. As of May 21, 2026, PIII trades at $10.33 with a market cap of $30.50M and a P/E ratio of -0.26. PIII moved -4.77% today. Year to date, PIII is +149.10%; over the trailing twelve months it is +22.04%. Its 52-week range spans $1.52 to $26.00. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces PIII's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
P3 Health Partners Stock Surges 180% on $26 Million Q1 EBITDA: P3 Health Partners stock surged 180.15% to $11.29 on May 15 after reporting $26 million in adjusted EBITDA for the first quarter. Trading volume topped 64 million shares, reflecting heightened investor interest in its improving operating performance.
| Metric | Value |
|---|---|
| Price | $10.33 |
| Market Cap | $30.50M |
| P/E Ratio | -0.26 |
| EPS | $-38.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.00 |
| 52-Week Low | $1.52 |
| Volume | 2.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.47B |
| Net Income | $-275.80M |
| Gross Margin | 0.00% |
2 analysts cover PIII: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.